MuSK and LRP4 — Drug Target

All drugs that target MuSK and LRP4 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Monoclonal antibody

Phase 2 pipeline (1)

• Efgartigimod IV or Efgartigimod PH20 SC · argenx · Monoclonal antibody · Neurology
  Monoclonal antibody targeting muscle relaxant proteins